155 related articles for article (PubMed ID: 10971746)
41. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.
Miguel DC; Yokoyama-Yasunaka JK; Andreoli WK; Mortara RA; Uliana SR
J Antimicrob Chemother; 2007 Sep; 60(3):526-34. PubMed ID: 17584801
[TBL] [Abstract][Full Text] [Related]
42. Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.
de Souza Carmo EV; Katz S; Barbiéri CL
PLoS One; 2010 Nov; 5(11):e13815. PubMed ID: 21082032
[TBL] [Abstract][Full Text] [Related]
43. In vivo activity of perifosine against Leishmania amazonensis.
Cabrera-Serra MG; Valladares B; Piñero JE
Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
[TBL] [Abstract][Full Text] [Related]
44. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
[TBL] [Abstract][Full Text] [Related]
45. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
Padigel UM; Alexander J; Farrell JP
J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
[TBL] [Abstract][Full Text] [Related]
46. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis.
Qi H; Ji J; Wanasen N; Soong L
Infect Immun; 2004 Feb; 72(2):988-95. PubMed ID: 14742545
[TBL] [Abstract][Full Text] [Related]
47. Th17 cells and neutrophils: Close collaborators in chronic Leishmania mexicana infections leading to disease severity.
Pedraza-Zamora CP; Delgado-Domínguez J; Zamora-Chimal J; Becker I
Parasite Immunol; 2017 Apr; 39(4):. PubMed ID: 28207936
[TBL] [Abstract][Full Text] [Related]
48. The potent cell permeable calpain inhibitor MDL28170 affects the interaction of Leishmania amazonensis with macrophages and shows anti-amastigote activity.
Marinho FA; Sangenito LS; Oliveira SSC; De Arruda LB; D'Ávila-Levy CM; Santos ALS; Branquinha MH
Parasitol Int; 2017 Oct; 66(5):579-583. PubMed ID: 28663009
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
Front Immunol; 2021; 12():759021. PubMed ID: 35154068
[TBL] [Abstract][Full Text] [Related]
50. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
Courret N; Lang T; Milon G; Antoine JC
Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
[TBL] [Abstract][Full Text] [Related]
51. Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival.
Rogers M; Kropf P; Choi BS; Dillon R; Podinovskaia M; Bates P; Müller I
PLoS Pathog; 2009 Aug; 5(8):e1000555. PubMed ID: 19696894
[TBL] [Abstract][Full Text] [Related]
52. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
Passelli K; Billion O; Tacchini-Cottier F
Front Immunol; 2021; 12():649348. PubMed ID: 33732265
[No Abstract] [Full Text] [Related]
53. Leishmania amazonensis infection in nude mice.
Terabe M; Hatabu T; Takahashi H; Ito M; Onodera T; Matsumoto Y
Exp Anim; 1999 Apr; 48(2):119-23. PubMed ID: 10374074
[TBL] [Abstract][Full Text] [Related]
54. The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.
Passero LF; Laurenti MD; Tomokane TY; Corbett CE; Toyama MH
Parasitol Res; 2008 Apr; 102(5):1025-33. PubMed ID: 18180953
[TBL] [Abstract][Full Text] [Related]
55. Macrophages From Subjects With Isolated GH/IGF-I Deficiency Due to a GHRH Receptor Gene Mutation Are Less Prone to Infection by
Barrios MR; Campos VC; Peres NTA; de Oliveira LL; Cazzaniga RA; Santos MB; Aires MB; Silva RLL; Barreto A; Goto H; Almeida RP; Salvatori R; Aguiar-Oliveira MH; Jesus AMR
Front Cell Infect Microbiol; 2019; 9():311. PubMed ID: 31544067
[TBL] [Abstract][Full Text] [Related]
56. Topical treatment of cutaneous leishmaniasis in Belize: in vitro and in vivo studies with Leishmania mexicana.
el-On J; Cawich F; Evans DA; Weinrauch L
Int J Parasitol; 1993 Feb; 23(1):121-7. PubMed ID: 8468127
[TBL] [Abstract][Full Text] [Related]
57. Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.
Reimão JQ; Trinconi CT; Yokoyama-Yasunaka JK; Miguel DC; Kalil SP; Uliana SR
J Microbiol Methods; 2013 May; 93(2):95-101. PubMed ID: 23466934
[TBL] [Abstract][Full Text] [Related]
58. Antileishmanial activity of cordiaquinone E towards Leishmania (Leishmania) amazonensis.
Rodrigues RRL; Nunes TAL; de Araújo AR; Marinho Filho JDB; da Silva MV; Carvalho FAA; Pessoa ODL; Freitas HPS; Rodrigues KADF; Araújo AJ
Int Immunopharmacol; 2021 Jan; 90():107124. PubMed ID: 33168414
[TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
[TBL] [Abstract][Full Text] [Related]
60. Experimental Cutaneous Leishmaniasis: Mouse Models for Resolution of Inflammation Versus Chronicity of Disease.
Bogdan C; Debus A; Sebald H; Rai B; Schäfer J; Obermeyer S; Schleicher U
Methods Mol Biol; 2019; 1971():315-349. PubMed ID: 30980313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
